OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanomedicine in cancer therapy
Dahua Fan, Yongkai Cao, Meiqun Cao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 234
Dahua Fan, Yongkai Cao, Meiqun Cao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 234
Showing 1-25 of 234 citing articles:
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Nanomedomics
Ganghao Liang, Wanqing Cao, Dongsheng Tang, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 10979-11024
Closed Access | Times Cited: 20
Ganghao Liang, Wanqing Cao, Dongsheng Tang, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 10979-11024
Closed Access | Times Cited: 20
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 15
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 15
Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application
Yuyuan Zhang, Mengjun Xu, Yuqing Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Yuyuan Zhang, Mengjun Xu, Yuqing Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives
Xiaoding Shen, Dayi Pan, Qiyong Gong, et al.
Bioactive Materials (2023) Vol. 32, pp. 445-472
Open Access | Times Cited: 26
Xiaoding Shen, Dayi Pan, Qiyong Gong, et al.
Bioactive Materials (2023) Vol. 32, pp. 445-472
Open Access | Times Cited: 26
Near‐Infrared Light‐Triggered MXene Nanocomposite for Tumor‐Specific Mild Photothermal‐Enhanced Chemodynamic Therapy
Peizheng Xiong, Xiaodan Wei, Li Zhou, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 44
Closed Access | Times Cited: 11
Peizheng Xiong, Xiaodan Wei, Li Zhou, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 44
Closed Access | Times Cited: 11
Bridging Smart Nanosystems with Clinically Relevant Models and Advanced Imaging for Precision Drug Delivery
Qiaoxia Zhou, Qiongliang Liu, Yan Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 10
Qiaoxia Zhou, Qiongliang Liu, Yan Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 10
Regulated cell death‐amplified sonodynamic anti‐tumor immune nanotherapeutics
Liqiang Zhou, Yangmengfan Chen, Dong Xie, et al.
BMEMat (2024)
Open Access | Times Cited: 10
Liqiang Zhou, Yangmengfan Chen, Dong Xie, et al.
BMEMat (2024)
Open Access | Times Cited: 10
Fusion of Exosomes and Nanotechnology: Cutting-Edge Cancer Theranostics
R. Agnihotram, Rajib Dhar, Debolina Dhar, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 8, pp. 8489-8506
Closed Access | Times Cited: 10
R. Agnihotram, Rajib Dhar, Debolina Dhar, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 8, pp. 8489-8506
Closed Access | Times Cited: 10
Phospholipid Membranes as Chemically and Functionally Tunable Materials
Daniel Huster, Sudipta Maiti, Andreas Herrmann
Advanced Materials (2024) Vol. 36, Iss. 23
Closed Access | Times Cited: 8
Daniel Huster, Sudipta Maiti, Andreas Herrmann
Advanced Materials (2024) Vol. 36, Iss. 23
Closed Access | Times Cited: 8
Nanoscale strides: exploring innovative therapies for breast cancer treatment
Sruthi Laakshmi Mugundhan, M. Mothilal
RSC Advances (2024) Vol. 14, Iss. 20, pp. 14017-14040
Open Access | Times Cited: 8
Sruthi Laakshmi Mugundhan, M. Mothilal
RSC Advances (2024) Vol. 14, Iss. 20, pp. 14017-14040
Open Access | Times Cited: 8
Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery
Mahmoud A. El-Meligy, Eman M. Abd El-Monaem, Abdelazeem S. Eltaweil, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2393-2393
Open Access | Times Cited: 8
Mahmoud A. El-Meligy, Eman M. Abd El-Monaem, Abdelazeem S. Eltaweil, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2393-2393
Open Access | Times Cited: 8
Hyaluronic acid-conjugated methotrexate and 5-fluorouracil for targeted drug delivery
Wanfei Shao, Yanfang Yang, Weidong Shen, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132671-132671
Closed Access | Times Cited: 8
Wanfei Shao, Yanfang Yang, Weidong Shen, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132671-132671
Closed Access | Times Cited: 8
Engineering peptide drug therapeutics through chemical conjugation and implication in clinics
Syed Faheem Askari Rizvi, Haixia Zhang, Quan Fang
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2420-2471
Closed Access | Times Cited: 6
Syed Faheem Askari Rizvi, Haixia Zhang, Quan Fang
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2420-2471
Closed Access | Times Cited: 6
Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine
Chinedu O. Egwu, Chinyere Aloke, Kenneth T. Onwe, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2584-2584
Open Access | Times Cited: 6
Chinedu O. Egwu, Chinyere Aloke, Kenneth T. Onwe, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2584-2584
Open Access | Times Cited: 6
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 6
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 6
Patient-Specific Nanoparticle Targeting in Human Leukemia Blood
Yi Ju, Shiyao Li, Abigail Er Qi Tan, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 29021-29035
Open Access | Times Cited: 6
Yi Ju, Shiyao Li, Abigail Er Qi Tan, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 29021-29035
Open Access | Times Cited: 6
Bioengineering chitosan–antibody/fluorescent quantum dot nanoconjugates for targeted immunotheranostics of non-hodgkin B-cell lymphomas
Sandhra M. Carvalho, Alexandra A.P. Mansur, Zélia Inês Portela Lobato, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139515-139515
Closed Access
Sandhra M. Carvalho, Alexandra A.P. Mansur, Zélia Inês Portela Lobato, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139515-139515
Closed Access
STIMULI-RESPONSIVE SUPRAMOLECULAR HYDROGELS FOR PACLITAXEL DELIVERY: PROGRESS AND PROSPECTS
Mohammad Qutub, Amol Tatode, Jayshree Taksande, et al.
Aspects of Molecular Medicine (2025) Vol. 5, pp. 100062-100062
Open Access
Mohammad Qutub, Amol Tatode, Jayshree Taksande, et al.
Aspects of Molecular Medicine (2025) Vol. 5, pp. 100062-100062
Open Access
Novel Modifications and Delivery Modes of Cyclic Dinucleotides for STING Activation in Cancer Treatment
Yanjun Lu, Zhiyan Li, Xudong Zhu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 181-197
Open Access
Yanjun Lu, Zhiyan Li, Xudong Zhu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 181-197
Open Access
Multifunctional nanoparticles for image-guided drug delivery in nuclear medicine: advancements and applications
Bilal AbdulMajeed Mukhlif, Muhammad Ikram Ullah, Subasini Uthirapathy, et al.
Journal of Radioanalytical and Nuclear Chemistry (2025)
Closed Access
Bilal AbdulMajeed Mukhlif, Muhammad Ikram Ullah, Subasini Uthirapathy, et al.
Journal of Radioanalytical and Nuclear Chemistry (2025)
Closed Access
A dual thermo/pH-sensitive hydrogel as 5-Fluorouracil carrier for breast cancer treatment
Kaijun Luo, Wenbin Hu
Anti-Cancer Drugs (2025)
Closed Access
Kaijun Luo, Wenbin Hu
Anti-Cancer Drugs (2025)
Closed Access
Metal‐Protein Hybrid Materials: Unlocking New Frontiers in Biomedical Applications
Yong Pan, Han Zhao, Wenyong Huang, et al.
Advanced Healthcare Materials (2025)
Open Access
Yong Pan, Han Zhao, Wenyong Huang, et al.
Advanced Healthcare Materials (2025)
Open Access
BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy
Shiman Lu, Zhaoqing Shi, Chendi Ding, et al.
Biomaterials (2025) Vol. 317, pp. 123101-123101
Closed Access
Shiman Lu, Zhaoqing Shi, Chendi Ding, et al.
Biomaterials (2025) Vol. 317, pp. 123101-123101
Closed Access
Dendrimer-Mediated Generation of a Metal-Phenolic Network for Antibody Delivery to Elicit Improved Tumor Chemo/Chemodynamic/Immune Therapy
Zhiqiang Wang, Yunqi Guo, Gaoming Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Zhiqiang Wang, Yunqi Guo, Gaoming Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
